Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
hUC-MSCs for Spinal Cord Injury
NCT02481440Phase 2Completed
- Start
- Mar 2018
- Primary completion
- Mar 2020
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of human umbilical cord mesenchymal stem cells in spinal cord injury (SCI). Primary endpoints: American Spinal Injury Association Total Score and SCI Functional Rating Scale of the International Association of Neurorestoratology Total Score. Started Mar 2018; status: completed.
02
Drugs
human umbilical cord mesenchymal stem cells
03
Conditions
spinal cord injury (SCI)
Beyond the preview
Go deeper on NCT02481440.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02481440.